Pharmaceutical Executive September 30, 2024
In this part of his Pharmaceutical Executive video interview, Jonathan Scheinberg, of the Northeast Science and Technology Center, discusses what specific areas of research and development are likely to benefit the most from this influx of of venture capital and federal funding.
How are the increased levels of venture capital and federal funding impacting the biotech industry, and what specific areas of research and development are likely to benefit the most from this influx of capital?
The thing over the past two years, when you know, the Fed started increasing rates. Capital became very dear. There was a decrease in overall liquidity in the system. And so I would argue that the venture capital after 2022 up and until a...
Today's Sponsors
Today's Sponsor